IDT's UNCOVERseq sets new benchmark for CRISPR off-target detection
Integrated DNA Technologies (IDT), a Danaher company, has announced the publication of a peer-reviewed Nature Communications study establishing a new analytical performance benchmark for CRISPR off-target nomination, providing evidence that can help gene editing developers prioritize biologically relevant sites for downstream confirmation and risk assessment.
The study, “UNCOVERseq Enables Sensitive and Controlled Gene Editing Off-Target Nomination Across CRISPR-Cas Modalities and Systems,” found that UNCOVERseq, IDT’s in cellulo workflow for nominating potential CRISPR off-target editing sites, delivered the strongest combined sensitivity and precision among the methods evaluated. The paper also addresses a critical challenge in therapeutic genome editing: determining whether nomination methods reliably identify biologically relevant sites while producing sufficiently precise results to guide subsequent evaluation.
In the new study, IDT and University of California, San Francisco scientists created an inter-method benchmarking dataset based on targeted confirmation of potential off-target sites, enabling performance to be assessed against empirically observed editing rather than the size of a method’s candidate list. Across the two guide RNAs used to calculate comparative performance, UNCOVERseq achieved 97.6% analytical sensitivity and 78% precision.
The research also defines operating conditions that influence off-target nomination, including biological replication, genomic DNA input, sequencing depth, library preparation, alignment criteria and process controls. The research team found that insufficient operating conditions can limit method performance, while low-precision approaches may generate large candidate lists that increase downstream confirmation burden, time and cost. By clarifying the conditions required for reproducible performance, the study provides a framework for advancing off-target assessment with greater speed and certainty without compromising analytical rigor.
